Survival rate in patients after sudden cardiac arrest at the university hospital of northern Norway treated with or without opioids: A retrospective evaluation

Vladimir Kuklin, Vladimir Kuklin

Abstract

Background: Experimental studies both in vivo and in vitro show significantly increased survival rate in animals and in cortical neurons respectively exposed to acute hypoxia and pre-treated with opioids compared to non-treated counterparts. Thus, the main aim of the study was to examine survival rates in patients after sudden cardiac arrest (SCA) in the hospital who were or were not treated with opioids before and/or during cardiac pulmonary resuscitation (CPR).

Methods: The registry SCA database at the University Hospital of Northern Norway (UNN) for the period of January 2006-December 2009 was used to obtain data for the evaluation. Inclusion criteria were observed SCA at UNN for patients with American Society of Anesthesiologists (ASA) 1-3. Exclusion criteria included ASA four to five patients and unobserved SCA. Study patients were divided into two groups: Those not treated with opioids and those treated with opioids not more then 3 h before and/or during CPR. Survival rate 1, 2, 3 and 28 days post CPR were compared for the two groups.

Results: A total of 117 patients were registered in the SCA database at UNN for the period from January 2006 to December 2009. Sixty seven patients were excluded from the study: 17 patients had an unknown time of SCA dιbut, two patients had only syncope and 48 were ASA four to five patients. A total of 50 ASA one to three patients were included in the study, 33 and 17 patients respectively in the control and opioid-treated groups. The patients who were treated with opioids before or during CPR had a significantly higher 1, 2, 3 and 28 days survival rate as compared to those receiving only conventional CPR. The model was adjusted for duration of CPR (P=0.047) and treatment with adrenaline (P=0.779) in the groups. Adjusted Odds ratio was 0.075 (95% confidence interval (CI): 0.015-0.387). Relative risk of fatal outcome in the opioids group was 0.2944 (95% CI: 0.1549-0.5594).

Conclusion: Significantly higher 1, 2, 3 and 28 days survival rate and reduced duration of CPR were found in the patients additionally treated with opioids compared to ordinary resuscitation. Further prospective, randomized, controlled trials are needed to investigate the effects of early administration of opioids during CPR on survival and brain function in patients with witnessed in-hospital SCA.

Keywords: Cardiac arrest; opioids; survival rate.

Conflict of interest statement

Conflict of Interest: None declared

References

    1. Walker A, McClelland H, Brenchley J. The Lazarus phenomenon following recreational drug use. Emerg Med J. 2001;18:74–5.
    1. Endoh H, Taga K, Yamakura T, Sato K, Watanabe I, Fukuda S, et al. Effects of naloxone and morphine on acute hypoxic survival in mice. Crit Care Med. 1999;27:1929–33.
    1. Endoh H, Honda T, Ohashi S, Shimoji K. Naloxone improves arterial blood pressure and hypoxic ventilatory depression, but not survival, of rats during acute hypoxia. Crit Care Med. 2001;29:623–7.
    1. Zhang J, Haddad GG, Xia Y. delta-, but not mu-and kappa-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury. Brain Res. 2000;885:143–53.
    1. Zhang J, Gibney GT, Zhao P, Xia Y. Neuroprotective role of delta-opioid receptors in cortical neurons. Am J Physiol Cell Physiol. 2002;282:C1225–34.
    1. Lim YJ, Zheng S, Zuo Z. Morphine preconditions Purkinje cells against cell death under in vitro simulated ischemia-reperfusion conditions. Anesthesiology. 2004;100:562–8.
    1. Mayfield KP, D’Alecy LG. Role of endogenous opioid peptides in the acute adaptation to hypoxia. Brain Res. 1992;582:226–31.
    1. Mayfield KP, D’Alecy LG. Delta-1 opioid agonist acutely increases hypoxic tolerance. J Pharmacol Exp Ther. 1994;268:683–8.
    1. Chien S, Oeltgen PR, Diana JN, Salley RK, Su TP. Extension of tissue survival time in multiorgan block preparation with a delta opioid DADLE (D-Ala2, D-Leu5-enkephalin) J Thorac Cardiovasc Surg. 1994;107:964–7.
    1. Meaney PA, Nadkarni VM, Kern KB, Indik JH, Halperin HR, Berg RA. Rhythms and outcomes of adult in-hospital cardiac arrest. Crit Care Med. 2010;38:101–8.
    1. Ishtiaq O, Iqbal M, Zubair M, Qayyum R, Adil M. Outcome of cardiopulmonary resuscitation-predictors of survival. J Coll Physicians Surg Pak. 2008;18:3–7.
    1. Fonnum F. Glutamate: A neurotransmitter in mammalian brain. J Neurochem. 1984;42:1–11.
    1. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988;1:623–34.
    1. Nicholls D, Attwell D. The release and uptake of excitatory amino acids. Trends Pharmacol Sci. 1990;11:462–8.
    1. Bondy SC, LeBel CP. The relationship between excitotoxicity and oxidative stress in the central nervous system. Free Radic Biol Med. 1993;14:633–42.
    1. Khodorov B, Pinelis V, Storozhevykh T, Vergun O, Vinskaya N. Dominant role of mitochondria in protection against a delayed neuronal Ca2+overload induced by endogenous excitatory amino acids following a glutamate pulse. FEBS Lett. 1996;393:135–8.
    1. Koerner IP, Brambrink AM. Brain protection by anesthetic agents. Curr Opin Anaesthesiol. 2006;19:481–6.
    1. Yamakura T, Sakimura K, Shimoji K. Direct inhibition of the N-methyl-D-aspartate receptor channel by high concentrations of opioids. Anesthesiology. 1999;91:1053–63.
    1. Zhang Y, Wu YX, Hao YB, Dun Y, Yang SP. Role of endogenous opioid peptides in protection of ischemic preconditioning in rat small intestine. Life Sci. 2001;68:1013–9.
    1. Addison PD, Neligan PC, Ashrafpour H, Khan A, Zhong A, Moses M, et al. Noninvasive remote ischemic preconditioning for global protection of skeletal muscle against infarction. Am J Physiol Heart Circ Physiol. 2003;285:H1435–43.
    1. Romano MA, Seymour EM, Berry JA, McNish RA, Bolling SF. Relative contribution of endogenous opioids to myocardial ischemic tolerance. J Surg Res. 2004;118:32–7.
    1. Peart JN, Gross GJ. Exogenous activation of delta-and kappa-opioid receptors affords cardioprotection in isolated murine heart. Basic Res Cardiol. 2004;99:29–37.
    1. Borlongan CV, Wang Y, Su TP. Delta opioid peptide (d-ala 2, d-leu 5) enkephalin: Linking hibernation and neuroprotection. Front Biosci. 2005;9:3392–8.
    1. Jones MK, Ross DT. The partial mu opiate agonist buprenorphine protects a sub-population of thalamic reticular neurons following cardiac arrest in rats. Neurosci Lett. 1995;185:91–4.
    1. Lee J, Kim MS, Park C, Jung EB, Choi DH, Kim TY, et al. Morphine prevents glutamate-induced death of primary rat neonatal astrocytes through modulation of intracellular redox. Immunopharmacol Immunotoxicol. 2004;26:17–28.
    1. Andree RA. Sudden death following naloxone administration. Anesth Analg. 1980;59:782–4.
    1. Cuss FM, Colaço CB, Baron JH. Cardiac arrest after reversal of effects of opiates with naloxone. Br Med J (Clin Res Ed) 1984;288:363–4.
    1. Deshpande G, Gill A. Cardiac arrest following naloxone in an extremely preterm neonate. Eur J Pediatr. 2009;168:115–7.
    1. Holmberg M, Holmberg S, Herlitz J. Low chance of survival among patients requiring adrenaline (epinephrine) or intubation after out-of-hospital cardiac arrest in Sweden. Resuscitation. 2002;54:37–45.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj